logo
Judge rules federal prisons must continue providing hormone therapy to transgender inmates

Judge rules federal prisons must continue providing hormone therapy to transgender inmates

Washington Post2 days ago

WASHINGTON — The federal Bureau of Prisons must continue providing hormone therapy and social accommodations to hundreds of transgender inmates following an executive order signed by President Donald Trump that led to a disruption in medical treatment, a federal judge ruled Tuesday .
U.S. District Judge Royce Lamberth said a federal law prohibits prison officials from arbitrarily depriving inmates of medications and other lifestyle accommodations that its own medical staff has deemed to be appropriate.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

I Forgot John Mulaney Was in This Movie in This Week's Netflix Top 10
I Forgot John Mulaney Was in This Movie in This Week's Netflix Top 10

CNET

time38 minutes ago

  • CNET

I Forgot John Mulaney Was in This Movie in This Week's Netflix Top 10

Every week, Netflix unveils its Top 10 lists for the week before, ranking TV shows and movies by viewership. As someone who covers streaming content (and also just watches a lot of TV), I keep an eye on the titles that come and go, and am always curious what hits and what doesn't. Last week, John Mulaney's Netflix animated series Big Mouth premiered a new season, and his Netflix talk show Everybody's Live with John Mulaney aired its season finale, so I was curious if either would crack the Netflix Top 10. Neither did, but ironically, a third Mulaney-involved title — Puss In Boots: The Last Wish — was in the No. 5 spot on the Netflix movie chart to my surprise, mostly because I forgot that he was even in it. (Sure, Puss In Boots: The Last Wish also stars Antonio Banderas, Salma Hayek, Harvey Guillen and Florence Pugh, but for the sake of argument, today it's a John Mulaney film.) Mulaney has been incredibly busy for the past few years, and it feels like the past two months reached peak Mulaney saturation: the eighth and final season of Big Mouth premiered on May 23, while his talk show Everybody's Live with John Mulaney aired its season finale on May 28 after running for 12 truly weird and unpredictable weeks. (For weeks, the show teased that the finale would feature Mulaney brawling with three 14-year-old boys. And yes, that fight did happen, rest assured no children were harmed.) Between both of his Netflix shows and recent appearances on Peacock's Poker Face and SNL 50, I think that his ubiquity is why I had forgotten all about his role as Jack Horner, the main villain in Puss In Boots: The Last Wish. It's certainly not because the role wasn't memorable, he actually stole every scene he was in as the narcissistic nursery rhyme character with an inferiority complex. Puss In Boots: The Last Wish, which debuted in theaters in 2022, is not actually available on Netflix in the U.S., which makes it even more impressive that it's dominating the Global Top 10 based on its popularity in Central and South America, where it peaked at No. 1 and has remained in the Top 10 film in dozens of countries for five weeks. DreamWorks Once I remembered Mulaney's pivotal role in the movie, I started to wonder, is this guy secretly Netflix's biggest star? He seems to have been given creative carte blanche on his talk shows and stand-up specials and, while his comedy can be niche, he also stars in projects with global appeal, so he very well could be. The streamer has deals with bigger names like Adam Sandler, Tyler Perry and Millie Bobby Brown, but I think Mulaney may be their ringer. He also starred in Spider-Man: Across the Spider-Verse, which was only just removed from Netflix in April, he has seven comedy specials on the platform, and he pops up in everything from Comedians In Cars Getting Coffee to this month's Conan O'Brien's Mark Twain Prize for American Humor special. He's in so many things that somehow they managed to overshadow The Last Wish in my mind. But the film, which has made almost $500 million globally, is hardly under the radar. Maybe while it remains in the Top 10, it will give him a chance to take a well-deserved break from Netflix and just chill. At least for a little while, before he starts plotting who to grapple on season 2 of Everybody's Live.

Novel Survey Effectively Screens Binge Eating in Diabetes
Novel Survey Effectively Screens Binge Eating in Diabetes

Medscape

time39 minutes ago

  • Medscape

Novel Survey Effectively Screens Binge Eating in Diabetes

A new diabetes-specific 10-item screening tool demonstrated excellent performance in detecting binge eating disorder in both patients with type 1 diabetes (T1D) and those with type 2 diabetes (T2D), showing strong associations with glycaemic control and mental health outcomes. METHODOLOGY: Although diabetes-specific screening for disordered eating behaviours is advised, the only available tool — the Diabetes Eating Problem Survey–Revised (DEPS-R) — is tailored for patients with T1D on rapid-acting insulin therapy, limiting its applicability across other diabetes types and treatment regimens. Researchers developed a 10-item non–insulin-specific version of the DEPS-R (DEPS-10) and evaluated its screening performance for binge eating disorder in 679 patients with T1D or T2D (mean age, 53.8 years) who had the disease for at least 1 year. The new survey assessed loss of control over eating, dietary and purging behaviours, and challenges in diabetes management. Researchers conducted a receiver operating characteristic curve analysis to test the screening performance of the DEPS-10 and compared it with those of the original DEPS-R and the Problem Areas In Diabetes (PAID) scale. TAKEAWAY: The point prevalence of binge eating disorder was 3.5% in the whole cohort, 2.9% in patients with T1D, and 4.3% in those with T2D. The DEPS-10 showed excellent screening performance for binge eating disorder (area under the curve [AUC], 0.92; P < .001), matching that of the DEPS-R (AUC, 0.92; P < .001) and surpassing that of the PAID scale (AUC, 0.82; P < .001). < .001), matching that of the DEPS-R (AUC, 0.92; < .001) and surpassing that of the PAID scale (AUC, 0.82; < .001). The DEPS-10 showed optimal sensitivity (87.5%) and specificity (86.9%) for detecting binge eating disorder at a cutoff score of greater than or equal to 15; participants with this cutoff score had higher body mass index and A1c level along with a greater psychological burden than those with scores below it. The stepwise approach of first screening with the PAID scale and then applying the DEPS-10 boosted specificity to 94%, compared with 87% when using the DEPS-10 alone and 67% when using the PAID scale alone. IN PRACTICE: "A two-step approach using the PAID followed by the DEPS-10 can be a feasible and time-efficient procedure in routine care," the authors wrote. SOURCE: This study was led by Laura Yvonne Klinker, Diabetes Center Mergentheim in Bad Mergentheim, Germany. It was published online on May 29, 2025, in Diabetic Medicine . LIMITATIONS: Higher DEPS-10 scores in one fifth of the participants may have been affected by glucagon-like peptide 1 therapy. Additionally, the relatively low positive predictive value of the DEPS-10 could have been attributed to its broader scope in detecting various disordered eating behaviours beyond binge eating disorder. DISCLOSURES: This study was funded by a grant from the German Center for Diabetes Research. The authors reported having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication. References Credit Lead image: Anastasiia Torianyk/Dreamstime Medscape News UK © 2025 WebMD, LLC Cite this: Novel Survey Effectively Screens Binge Eating in Diabetes - Medscape - June 05, 2025.

How Hard Will Musk Fight Republicans' Budget Bill?
How Hard Will Musk Fight Republicans' Budget Bill?

New York Times

time40 minutes ago

  • New York Times

How Hard Will Musk Fight Republicans' Budget Bill?

Can Musk kill the budget bill? Elon Musk hasn't stopped criticizing the budget bill that he has called a 'disgusting abomination.' In fact, he appears to be just getting started. The debate in Washington now is how far Musk will go to try to defeat a bill that — by the assessment of Musk, several Republicans and now nonpartisan watchdogs — will vastly add to the federal debt. 'KILL THE BILL,' Musk posted on X on Wednesday, a message he urged followers to press with members of Congress. He has turned a majority of his feed into a stream of reposts of content criticizing the legislation and denouncing its effect on the nation's $36 trillion debt load. A string of assessments suggest that the bill will add to the debt. The most consequential, the nonpartisan Congressional Budget Office, estimated that the House version of the plan would add $2.4 trillion over the next decade, given both the roughly $3.8 trillion tax cut at its core and additional spending. (Other estimates are even higher, including the Penn Wharton Budget Model's: $2.8 trillion.) A Republican counter: Attack the messenger. The Trump administration advanced hard-to-believe claims about C.B.O. staff members' partisanship, and arguments that its analysis ignores projected economic growth. That said, a previous nonpartisan analysis of the House bill found that the tax cuts would generate nearly no additional economic growth, and even conservatives found the budget office's analysis credible. 'When all the models are in unison,' Erica York, the vice president for federal tax policy at the Tax Foundation, told The Times, 'it really doesn't make sense to triple down on the strategy to blame the scorekeeper.' Want all of The Times? Subscribe.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store